Goldman Sachs' CEO said the drawdown is likely to come in the next one to two years, while Morgan Stanley's boss said this ...

Concerns are mounting that the bullish stock market is due for a downturn, especially if AI stocks have been overvalued.

The bloodbath began at the Global Financial Leaders’ Investment Summit in Hong Kong. On stage, Goldman Sachs CEO David ...

Stocks were down sharply across the world, with major indexes in the U.S., Europe and Asia all lower as of Tuesday morning, after comments by corporate chief executives about high equity valuations ...

Some of Wall Street’s top bosses see a stock pullback on the horizon, but that's no reason to get out of the market, they say.

Enthusiasm about artificial intelligence and the companies that produce AI services has been overflowing for months.

Now, it’s worth noting Stock Advisor's total average return is 1,076% — a market-crushing outperformance compared to 195% for ...

Live Updates Live Coverage Has Ended Get The Best Vanguard S&P 500 ETF Live Earnings Coverage Like This Every Quarter Get earnings reminders, our top analysis on Vanguard S&P 500 ETF, market updates, ...

Guardant Health, Inc. ("Guardant Health") (Nasdaq: GH), a leading precision oncology company, today announced the ...

Analysts turn cautious on Gland Pharma as Goldman Sachs cuts target to Rs 1,700 and maintains a ‘Sell’ view, while Jefferies and Nomura stay neutral; near-term growth seen muted despite strong ...

CTAs are expected to be small sellers of equities across all market scenarios in the coming week, according to Goldman Sachs equity derivatives and flows speciali ...

Major stock indices showed signs of weakness amid growing concerns over high market valuations. The S&P 500 declined 0.7% as ...